No Data
Behind the Scenes of Novo Nordisk's Latest Options Trends
Here's Why Novo Nordisk A/S (NVO) Slid in Q3
3 Healthcare Stocks to Buy for a 2025 Rebound
Top Gap Ups and Downs on Thursday: TM, LI, KB and More
Novo-Nordisk A/S faces another blow: Musk shares a weight loss photo, claiming that using Eli Lilly and Co's weight loss drug is more effective than semaglutide.
On Christmas, Musk shared a photo and called himself the Ozempic Santa Claus, clarifying that he didn't mean the drug name Ozempic for semaglutide, but rather Eli Lilly and Co's competitor Mounjaro. He also mentioned that "high doses" of Ozempic would make him fart and burp, adding that "Mounjaro seems to have fewer side effects and is more effective."
Novo-Nordisk A/S Options Spot-On: On December 26th, 96,143 Contracts Were Traded, With 459.29K Open Interest
104176897 : Thrash the shortie